Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 133rd ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
XBIT	XBIOTECH INC	$2.40	-5.88%	-3.23%	-13.36%	-12.73%	-13.04%	-65.37%	-24.53%	-87.32%	-78.65%	$7.00	$2.09	65.71%	14.83%	1.06	51,000	-34.62%
XBIO	XENETIC BIOSCIENCES INC	$2.44	0.83%	-3.56%	-7.58%	-32.22%	-24.69%	-41.89%	-43.26%	-87.86%	N/A	$13.93	$2.20	82.48%	10.91%	0.88	21,700	-30.00%
SONN	SONNET BIOTHERAPEUTICS HOLDINGS INC	$1.26	-59.35%	-69.71%	-68.73%	-60.25%	7.69%	-51.72%	-99.33%	-99.98%	-100.00%	$19.30	$1.08	93.47%	16.67%	0.93	10,114,000	1,026.28%
SCNI	SCINAI IMMUNOTHERAPEUTICS LTD	$1.20	-2.44%	0.00%	9.59%	-23.08%	-48.50%	-64.39%	-98.88%	-99.63%	-99.67%	$6.18	$0.86	80.58%	39.53%	0.94	18,200	171.64%
PRTC	PURETECH HEALTH PLC	$16.91	0.59%	0.71%	3.49%	3.68%	-12.16%	-23.31%	-50.12%	-62.04%	N/A	$23.35	$13.30	27.58%	27.14%	0.50	900	-77.50%
PPCB	PROPANC BIOPHARMA INC	$0.79	-2.35%	-6.08%	-5.85%	-64.50%	N/A	N/A	N/A	N/A	N/A	$9.36	$0.73	91.58%	7.95%	1.54	15,600	-78.33%
PPBT	PURPLE BIOTECH LTD	$0.75	-8.52%	-9.51%	-4.69%	31.70%	-69.43%	-79.45%	-97.64%	-99.09%	-99.89%	$5.20	$0.53	85.54%	41.09%	0.70	511,000	-95.18%
PHAR	PHARMING GROUP NV	$17.98	1.41%	7.34%	4.84%	22.48%	55.47%	92.92%	47.86%	N/A	N/A	$18.12	$7.50	0.77%	139.67%	0.54	59,000	273.42%
ASBP	ASPIRE BIOPHARMA HOLDINGS INC	$0.10	-8.65%	4.40%	-11.21%	-77.65%	-75.00%	-99.17%	-99.07%	N/A	N/A	$15.80	$0.07	99.40%	33.80%	0.41	55,480,000	63.49%
OGEN	ORAGENICS INC	$0.91	-1.72%	3.86%	-21.21%	-24.46%	-80.26%	-90.65%	-99.73%	-99.88%	-100.00%	$18.90	$0.82	95.16%	11.46%	0.98	400,000	2,677.78%
SYBX	SYNLOGIC INC	$1.11	0.91%	7.77%	-33.93%	-30.19%	-9.76%	-26.97%	-89.70%	-97.09%	-99.87%	$1.96	$0.90	43.37%	23.61%	0.82	26,500	-24.29%
SER	SERINA THERAPEUTICS INC	$3.12	-0.64%	-4.00%	-22.39%	-39.88%	-47.34%	-33.62%	-84.71%	-94.62%	N/A	$7.91	$3.12	60.56%	0.03%	0.22	12,700	7.63%
SXTP	60 DEGREES PHARMACEUTICALS INC	$0.85	-2.29%	-12.23%	-30.57%	-39.00%	-62.54%	-89.65%	N/A	N/A	N/A	$8.70	$0.84	90.18%	1.67%	-0.32	94,000	-70.16%
NTRB	NUTRIBAND INC	$5.10	2.62%	5.81%	-12.97%	-28.67%	-32.89%	24.39%	36.36%	-58.97%	N/A	$11.78	$3.72	56.71%	37.02%	0.77	10,700	-84.93%
KLTO	KLOTHO NEUROSCIENCES INC	$0.40	-5.66%	-20.16%	-22.33%	-32.20%	-80.00%	-9.30%	-96.02%	N/A	N/A	$3.91	$0.11	89.77%	250.88%	0.70	935,000	87.37%
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$30.35	1.20%	-7.69%	-7.89%	-24.99%	-5.22%	N/A	N/A	N/A	N/A	$48.45	$17.00	37.36%	78.53%	0.60	500	-64.29%
SGMO	SANGAMO THERAPEUTICS INC	$0.45	-1.96%	-9.27%	-4.26%	-10.89%	-10.54%	-76.44%	-87.18%	-96.56%	-94.61%	$2.84	$0.39	84.15%	16.88%	1.62	4,439,000	5.89%
NEUP	NEUPHORIA THERAPEUTICS INC	$4.08	2.51%	-4.45%	-16.73%	-68.64%	-42.86%	12.46%	-94.89%	N/A	N/A	$21.40	$2.77	80.93%	47.45%	0.77	104,000	-69.50%
TCRT	ALAUNOS THERAPEUTICS INC	$4.26	-0.23%	18.01%	42.47%	84.42%	41.86%	104.81%	-95.75%	-99.08%	-99.67%	$6.20	$1.31	31.29%	224.20%	1.14	51,400	41.21%
NRXS	NEURAXIS INC	$2.65	0.76%	-0.75%	1.92%	9.50%	15.22%	0.38%	N/A	N/A	N/A	$6.20	$1.33	57.26%	99.25%	1.03	40,000	-10.71%
MTNB	MATINAS BIOPHARMA HOLDINGS INC	$0.79	-0.38%	0.00%	-37.80%	-56.83%	-10.23%	35.97%	-97.53%	-98.54%	N/A	$3.09	$0.48	74.43%	66.32%	1.00	19,400	-50.26%
AEON	AEON BIOPHARMA INC	$0.82	8.16%	22.32%	-9.87%	5.38%	-7.85%	-98.39%	-99.89%	N/A	N/A	$51.26	$0.38	98.40%	119.20%	0.18	241,000	74.64%
MRUS	MERUS NV	$96.93	0.31%	0.82%	0.93%	39.31%	75.00%	133.85%	611.67%	474.57%	N/A	$96.94	$33.19	0.01%	192.05%	0.98	709,000	-35.72%
MRSN	MERSANA THERAPEUTICS INC	$28.35	0.43%	2.07%	219.62%	297.06%	212.33%	-50.70%	-83.20%	-95.56%	N/A	$56.00	$5.21	49.38%	444.15%	1.39	76,000	126.87%
MNOV	MEDICINOVA INC	$1.54	1.99%	-1.28%	-1.91%	25.20%	11.59%	-28.04%	-40.31%	-74.33%	-56.50%	$2.24	$1.13	31.13%	36.28%	0.74	69,000	60.47%
MLEC	MOOLEC SCIENCE SA	$0.44	0.23%	-6.64%	-27.33%	-68.41%	-93.71%	-94.81%	-99.57%	N/A	N/A	$10.47	$0.39	95.84%	11.22%	0.39	20,000	-89.74%
MTVA	METAVIA INC	$9.31	8.76%	13.79%	19.88%	21.60%	12.85%	-63.28%	-93.04%	-99.94%	N/A	$30.25	$6.05	69.22%	53.88%	0.40	80,600	12.73%
LYRA	LYRA THERAPEUTICS INC	$3.64	-9.13%	-14.87%	-6.31%	-42.21%	-69.32%	-64.01%	-97.29%	-99.25%	N/A	$37.50	$2.84	90.31%	27.99%	0.60	65,000	722.78%
TOVX	THERIVA BIOLOGICS INC	$0.22	-6.87%	-5.65%	-27.18%	-47.71%	-56.60%	-81.76%	-98.58%	-99.75%	-100.00%	$2.08	$0.20	89.57%	9.60%	0.84	1,798,000	-10.95%
LPCN	LIPOCINE INC	$3.17	-0.31%	0.63%	8.56%	6.55%	0.32%	-39.73%	-55.04%	-86.08%	-98.37%	$5.50	$2.52	42.36%	25.79%	0.79	18,200	2.25%
JAGX	JAGUAR HEALTH INC	$1.35	-6.25%	25.00%	-22.86%	-31.12%	-64.75%	-94.46%	-99.99%	-100.00%	-100.00%	$33.25	$1.00	95.94%	35.00%	1.42	186,000	-57.63%
ITRM	ITERUM THERAPEUTICS PLC	$0.45	-4.05%	-4.66%	-24.87%	-34.02%	-54.82%	-77.27%	-60.53%	-96.91%	N/A	$2.10	$0.36	78.57%	24.31%	1.19	523,000	61.42%
INDP	INDAPTUS THERAPEUTICS INC	$2.44	-5.06%	-2.40%	-15.57%	-5.43%	-74.30%	-91.37%	-94.81%	-99.47%	-99.98%	$47.60	$1.65	94.87%	47.88%	1.19	13,600	23.64%
ICU	SEASTAR MEDICAL HOLDING CORP	$0.32	-5.87%	-10.58%	-35.67%	-63.10%	-74.11%	-83.02%	-99.70%	N/A	N/A	$3.07	$0.29	89.54%	10.69%	0.12	656,000	28.88%
RNA	AVIDITY BIOSCIENCES INC	$71.83	0.32%	0.28%	1.43%	60.55%	123.49%	112.77%	524.61%	118.46%	N/A	$71.88	$21.51	0.07%	233.94%	1.22	1,588,000	-12.41%
REVB	REVELATION BIOSCIENCES INC	$1.05	-8.70%	1.45%	6.92%	-45.31%	-56.52%	-94.70%	-99.99%	-100.00%	N/A	$60.48	$0.83	98.26%	26.51%	1.06	235,000	3.07%
PTN	PALATIN TECHNOLOGIES INC	$27.25	10.46%	18.48%	146.83%	215.03%	460.12%	-36.32%	-84.16%	-95.01%	-96.84%	$72.50	$1.75	62.41%	1,457.14%	1.25	43,000	-63.25%
IPHA	INNATE PHARMA SA	$1.86	0.54%	-1.59%	-3.13%	-7.00%	-5.82%	20.00%	-15.45%	-57.63%	N/A	$2.67	$1.60	30.34%	16.25%	0.59	24,200	310.17%
CLDI	CALIDI BIOTHERAPEUTICS INC	$1.46	-0.68%	0.00%	-3.31%	-9.88%	-64.57%	-93.49%	-99.88%	N/A	N/A	$22.30	$1.10	93.45%	32.73%	0.46	37,300	-32.18%
MOLN	MOLECULAR PARTNERS AG	$4.33	-3.46%	-4.31%	4.72%	16.26%	10.90%	-22.07%	-35.45%	N/A	N/A	$5.91	$3.36	26.82%	28.72%	0.51	500	-61.54%
IMRN	IMMURON LTD	$1.02	-2.86%	-32.45%	-36.65%	-47.15%	-41.71%	-53.64%	-49.90%	-85.43%	N/A	$2.48	$1.00	58.92%	2.00%	0.75	53,000	-79.05%
PCSA	PROCESSA PHARMACEUTICALS INC	$0.27	-0.74%	-2.88%	-17.18%	42.11%	-21.51%	-78.40%	-99.34%	-99.83%	-99.92%	$1.10	$0.15	75.45%	80.00%	0.89	604,000	-43.29%
VRAX	VIRAX BIOLABS GROUP LTD	$0.45	2.48%	-27.94%	-1.52%	-23.83%	-52.71%	-71.80%	-96.18%	N/A	N/A	$3.20	$0.35	85.81%	29.71%	0.75	302,000	-25.25%
EXOZ	EXOZYMES INC	$14.34	-9.81%	-2.61%	-13.09%	15.65%	9.05%	-8.14%	N/A	N/A	N/A	$23.99	$8.86	40.23%	61.85%	0.57	4,200	31.25%
IGC	IGC PHARMA INC	$0.35	5.45%	16.78%	-4.92%	-15.12%	12.26%	-11.00%	-11.00%	-78.91%	49.36%	$0.50	$0.25	30.12%	37.55%	0.83	1,387,000	77.14%
PLUR	PLURI INC	$3.08	-0.32%	-6.10%	-30.79%	-37.65%	-28.37%	-35.97%	-58.82%	-93.72%	-96.37%	$7.13	$3.02	56.80%	2.16%	0.85	15,100	-87.52%
TVGN	TEVOGEN BIO HOLDINGS INC	$0.40	-6.05%	0.75%	-13.30%	-53.35%	-68.19%	-60.00%	-96.07%	N/A	N/A	$1.92	$0.38	78.96%	6.32%	0.44	785,000	1.03%
VYNE	VYNE THERAPEUTICS INC	$0.38	-7.16%	1.62%	6.82%	20.90%	-57.75%	-84.33%	-88.18%	-99.69%	N/A	$4.30	$0.28	91.26%	33.81%	1.16	1,239,000	22.79%
ATHE	ALTERITY THERAPEUTICS LTD	$3.29	-3.80%	-3.80%	-13.19%	-32.58%	-28.32%	48.20%	-2.52%	-78.07%	-92.49%	$7.00	$2.04	53.00%	61.27%	0.70	17,100	317.07%
SNSE	SENSEI BIOTHERAPEUTICS INC	$8.55	-5.00%	-12.04%	-15.35%	-4.79%	27.42%	-0.60%	-75.15%	N/A	N/A	$18.35	$5.00	53.41%	71.00%	0.96	22,600	-45.93%
VTVT	VTV THERAPEUTICS INC	$34.63	1.55%	26.62%	11.71%	75.25%	116.44%	120.57%	8.67%	-70.85%	-86.62%	$35.95	$13.15	3.67%	163.35%	0.85	6,000	-15.49%
IBO	IMPACT BIOMEDICAL INC	$0.49	-0.41%	6.11%	-6.72%	-31.55%	2.75%	-77.40%	N/A	N/A	N/A	$6.17	$0.36	92.12%	34.25%	-0.82	140,000	348.72%
GOVX	GEOVAX LABS INC	$0.38	-3.35%	-0.53%	-24.70%	-46.58%	-67.11%	-84.38%	-96.24%	-99.23%	-100.00%	$2.75	$0.37	86.36%	2.74%	1.43	376,000	-50.40%
EDSA	EDESA BIOTECH INC	$1.74	-1.69%	-1.14%	-2.79%	-27.50%	-11.00%	-3.33%	-72.98%	-95.01%	-99.93%	$4.49	$1.55	61.25%	12.26%	0.90	39,300	0.26%
CSBR	CHAMPIONS ONCOLOGY INC	$6.72	6.67%	11.26%	-2.18%	-1.61%	-9.13%	30.23%	5.99%	-41.82%	85.64%	$11.99	$5.59	43.95%	20.17%	0.40	12,800	228.21%
ONCO	ONCONETIX INC	$2.30	-0.43%	-10.68%	-16.36%	-24.59%	-63.43%	-94.21%	-99.95%	N/A	N/A	$179.35	$2.10	98.72%	9.52%	0.80	47,000	-53.92%
KPRX	KIORA PHARMACEUTICALS INC	$2.14	-0.23%	5.17%	-7.38%	-19.13%	-30.68%	-39.21%	-92.83%	-99.84%	-99.98%	$4.18	$1.76	48.92%	21.03%	0.86	13,000	-69.77%
RADX	RADIOPHARM THERANOSTICS LTD	$4.26	-0.47%	-10.32%	-9.01%	-34.46%	-20.08%	-26.55%	N/A	N/A	N/A	$11.00	$3.50	61.27%	21.85%	0.62	850	-91.33%
INTS	INTENSITY THERAPEUTICS INC	$0.47	-20.34%	-7.84%	-8.20%	102.59%	46.88%	-77.24%	N/A	N/A	N/A	$3.17	$0.19	85.15%	154.05%	-0.29	7,038,000	67.13%
ADXN	ADDEX THERAPEUTICS LTD	$8.10	6.79%	-3.34%	-8.06%	-7.74%	-10.05%	2.66%	-36.67%	-96.57%	N/A	$12.05	$6.51	32.78%	24.42%	0.41	4,600	N/A
XCUR	EXICURE INC	$6.35	4.61%	29.59%	76.39%	63.87%	-29.37%	-63.71%	67.11%	-97.16%	N/A	$22.99	$3.10	72.38%	104.77%	0.81	216,000	-61.36%
ANEB	ANEBULO PHARMACEUTICALS INC	$2.29	2.23%	1.33%	-3.38%	-3.38%	80.31%	64.75%	-29.75%	N/A	N/A	$3.42	$0.80	33.04%	186.25%	0.51	1,000	-95.24%
AKTX	AKARI THERAPEUTICS PLC	$0.39	-5.12%	14.75%	-28.36%	-50.70%	-66.78%	-59.05%	-96.28%	-99.00%	-99.88%	$1.73	$0.27	77.51%	46.79%	0.42	489,000	35.08%
MBIO	MUSTANG BIO INC	$1.20	-2.05%	-4.40%	-4.40%	-24.37%	-5.91%	-88.34%	-99.62%	-99.94%	N/A	$21.95	$0.89	94.56%	33.82%	1.51	71,500	25.44%
ERNA	ERNEXA THERAPEUTICS INC	$1.36	-8.11%	3.03%	-15.53%	5.43%	-42.62%	-68.71%	-98.00%	-99.89%	-99.97%	$14.40	$1.09	90.56%	24.77%	1.20	32,000	-61.90%
CMND	CLEARMIND MEDICINE INC	$0.07	2.78%	-42.64%	-76.13%	-92.75%	-91.36%	-94.93%	-99.92%	N/A	N/A	$2.18	$0.07	96.61%	12.12%	0.31	11,472,000	-28.56%
JUNS	JUPITER NEUROSCIENCES INC	$1.12	-5.08%	-1.75%	-18.84%	-26.32%	0.00%	-92.71%	N/A	N/A	N/A	$19.51	$0.51	94.26%	119.61%	0.19	34,400	-67.55%
FBLG	FIBROBIOLOGICS INC	$0.39	12.93%	48.86%	19.82%	-27.62%	-54.98%	-82.69%	N/A	N/A	N/A	$2.51	$0.24	84.34%	63.75%	0.42	1,811,000	21.87%
VIVS	VIVOSIM LABS INC	$2.22	-1.77%	-4.31%	-1.77%	-47.02%	28.32%	-54.66%	-89.61%	-97.51%	-99.65%	$21.96	$1.41	89.89%	57.45%	0.73	79,500	103.85%
ANL	ADLAI NORTYE LTD	$1.38	7.81%	36.63%	-14.29%	-22.69%	-13.75%	-37.27%	N/A	N/A	N/A	$2.99	$0.88	53.85%	57.00%	0.65	46,400	0.00%
RNAZ	TRANSCODE THERAPEUTICS INC	$9.51	-8.73%	10.45%	8.07%	-11.12%	31.99%	-95.29%	-100.00%	N/A	N/A	$468.44	$6.15	97.97%	54.68%	1.37	17,200	-80.56%
XTLB	XTL BIOPHARMACEUTICALS LTD	$0.85	0.00%	0.00%	-12.37%	-37.04%	-29.17%	-53.04%	-36.57%	-67.68%	-89.17%	$2.57	$0.77	66.93%	10.39%	0.68	9,200	-51.58%
PMCB	PHARMACYTE BIOTECH INC	$1.02	0.00%	-16.39%	19.86%	-1.92%	0.00%	-38.92%	-64.21%	-88.04%	-99.09%	$1.90	$0.63	46.32%	61.90%	0.47	686,000	-54.05%
INAB	IN8BIO INC	$1.68	-2.89%	-5.08%	-1.18%	-20.00%	-29.41%	-80.73%	-97.73%	N/A	N/A	$12.53	$1.53	86.59%	9.80%	1.01	86,000	168.75%
XRTX	XORTX THERAPEUTICS INC	$0.61	-0.16%	-3.33%	6.09%	-26.15%	-30.68%	-47.41%	-91.84%	N/A	N/A	$1.79	$0.52	65.92%	18.45%	0.22	38,000	84.47%
PTIX	PROTAGENIC THERAPEUTICS INC	$1.65	4.43%	-1.20%	-14.06%	-48.76%	-53.13%	-77.12%	-93.15%	-97.19%	-99.62%	$14.28	$1.46	88.45%	13.01%	-0.12	114,000	165.12%
COCP	COCRYSTAL PHARMA INC	$1.05	-0.94%	2.94%	-4.55%	-33.54%	-31.82%	-43.55%	-60.53%	-94.21%	N/A	$3.26	$0.90	67.79%	16.67%	0.67	52,000	44.44%
ATHA	ATHIRA PHARMA INC	$3.87	-2.03%	-2.03%	-17.66%	7.50%	25.04%	-33.51%	-87.98%	-98.72%	N/A	$6.09	$2.20	36.45%	76.31%	1.28	18,000	-12.20%
INM	INMED PHARMACEUTICALS INC	$1.43	2.88%	0.00%	-17.34%	-33.18%	-46.84%	-72.23%	-96.33%	-99.91%	N/A	$8.27	$1.13	82.71%	26.55%	1.22	387,000	230.77%
BRNS	BARINTHUS BIOTHERAPEUTICS PLC	$0.68	-5.69%	-5.83%	-16.07%	-38.27%	-25.71%	-17.20%	-71.11%	N/A	N/A	$2.92	$0.64	76.75%	6.09%	0.86	140,000	-20.90%
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	$1.81	-4.74%	-9.95%	-4.23%	-30.92%	7.74%	-53.47%	-79.31%	-80.30%	N/A	$4.98	$1.31	63.65%	38.17%	0.48	24,100	-23.73%
ENSC	ENSYSCE BIOSCIENCES INC	$1.43	0.35%	-13.11%	-30.83%	-32.46%	-33.41%	-76.72%	-99.23%	-100.00%	N/A	$10.96	$1.26	87.00%	13.10%	1.08	89,000	-68.21%
CANF	CAN-FITE BIOPHARMA LTD	$0.28	-2.41%	-8.71%	-26.87%	-57.12%	-73.80%	-82.64%	-96.23%	-98.56%	-99.93%	$2.33	$0.28	87.85%	1.07%	0.57	621,000	-19.14%
LSTA	LISATA THERAPEUTICS INC	$2.00	-1.96%	1.52%	-7.41%	-8.68%	-21.84%	-26.74%	-33.55%	-90.80%	-98.72%	$4.20	$1.81	52.38%	10.50%	0.80	13,800	-33.33%
ADAG	ADAGENE INC	$1.75	-0.79%	-12.06%	-1.13%	-21.88%	-10.71%	-17.06%	33.59%	N/A	N/A	$3.16	$1.30	44.62%	34.62%	0.32	81,000	113.16%
EVGN	EVOGENE LTD	$1.08	-0.92%	-2.70%	-13.60%	-14.96%	-28.95%	-18.80%	-83.51%	-97.27%	-98.34%	$2.42	$0.95	55.37%	13.68%	1.00	22,400	20.43%
BOLD	BOUNDLESS BIO INC	$1.17	1.74%	2.63%	-4.88%	1.74%	7.34%	-60.34%	N/A	N/A	N/A	$3.12	$1.00	62.50%	17.00%	1.34	46,000	-36.46%
DYAI	DYADIC INTERNATIONAL INC	$0.91	-1.41%	-4.11%	-3.19%	-5.79%	-3.50%	-43.77%	-28.27%	-84.97%	N/A	$2.20	$0.71	58.59%	28.13%	0.84	31,400	-91.84%
BOLT	BOLT BIOTHERAPEUTICS INC	$5.44	-7.17%	0.37%	15.99%	5.04%	-12.68%	-48.54%	-79.24%	N/A	N/A	$12.60	$4.41	56.82%	23.36%	0.90	74,000	770.59%
CALC	CALCIMEDICA INC	$4.33	-5.66%	-0.92%	29.64%	36.59%	147.43%	55.20%	-46.77%	-98.64%	N/A	$4.82	$1.42	10.07%	204.93%	0.41	61,000	-58.50%
BGMS	BIO GREEN MED SOLUTION INC	$1.44	-4.00%	-13.25%	0.00%	-77.38%	-73.26%	-98.36%	-99.95%	-99.99%	-100.00%	$213.60	$1.16	99.33%	24.14%	0.67	16,600	-19.02%
BIVI	BIOVIE INC	$1.45	-3.97%	-8.23%	-9.94%	-22.46%	-87.82%	-94.40%	-99.85%	-99.88%	N/A	$27.00	$1.25	94.63%	16.00%	1.60	71,000	177.34%
CUE	CUE BIOPHARMA INC	$0.49	-1.22%	-11.29%	-27.10%	-34.37%	-23.43%	-53.40%	-84.19%	-96.42%	N/A	$1.75	$0.47	72.17%	4.51%	1.39	396,000	-9.59%
BDRX	BIODEXA PHARMACEUTICALS PLC	$4.75	-24.60%	-5.75%	-11.55%	-21.10%	-56.82%	-89.28%	-100.00%	-100.00%	-100.00%	$92.00	$3.58	94.84%	32.68%	1.04	454,000	-29.17%
CURX	CURANEX PHARMACEUTICALS INC	$0.45	-1.30%	4.37%	-21.18%	-94.72%	N/A	N/A	N/A	N/A	N/A	$9.18	$0.38	95.05%	20.74%	2.51	106,000	73.77%
DRMA	DERMATA THERAPEUTICS INC	$2.63	-4.36%	-6.07%	-15.71%	-51.34%	-64.17%	-75.87%	-99.44%	N/A	N/A	$23.70	$2.34	88.90%	12.39%	0.59	55,000	19.57%
CRIS	CURIS INC	$1.16	-10.08%	-14.07%	-5.69%	-36.26%	-58.12%	-68.82%	-91.08%	-99.29%	-99.59%	$4.50	$1.02	74.22%	13.73%	0.88	138,000	109.09%
CDTX	CIDARA THERAPEUTICS INC	$220.65	0.21%	0.13%	105.98%	236.25%	809.52%	919.64%	1,993.45%	438.17%	-28.13%	$221.20	$15.22	0.25%	1,349.74%	0.78	626,000	-18.81%
ENTX	ENTERA BIO LTD	$2.16	-2.26%	0.47%	-25.77%	20.00%	3.35%	-1.82%	245.60%	101.87%	N/A	$3.22	$1.50	32.92%	43.90%	0.62	96,000	84.62%
CYCN	CYCLERION THERAPEUTICS INC	$1.51	-10.12%	-10.12%	6.34%	-38.62%	-51.29%	-57.70%	-91.27%	-97.69%	N/A	$6.25	$1.28	75.84%	17.97%	1.01	63,000	64.06%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Dec 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Beone Medicines (NASDAQ:ONC)

Beone Medicines (NASDAQ:ONC) is the #1 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Beone Medicines (NASDAQ:ONC) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: C, and AI: B.

Beone Medicines (NASDAQ:ONC) has a Due Diligence Score of 53, which is 30 points higher than the biotech industry average of 23.

ONC passed 18 out of 33 due diligence checks and has strong fundamentals. Beone Medicines has seen its stock return 76.99% over the past year, overperforming other biotech stocks by 122 percentage points.

Beone Medicines has an average 1 year price target of $390.88, an upside of 22.51% from Beone Medicines's current stock price of $319.06.

Beone Medicines stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Beone Medicines, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: C, Momentum: B, Sentiment: B, Safety: C, Financials: A, and AI: B.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 46, which is 23 points higher than the biotech industry average of 23.

AUPH passed 15 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 63.57% over the past year, overperforming other biotech stocks by 109 percentage points.

Aurinia Pharmaceuticals has an average 1 year price target of $17.25, an upside of 8.83% from Aurinia Pharmaceuticals's current stock price of $15.85.

Aurinia Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Aurinia Pharmaceuticals, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the #3 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Innoviva (NASDAQ:INVA) is: Value: A, Growth: C, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Innoviva (NASDAQ:INVA) has a Due Diligence Score of 45, which is 22 points higher than the biotech industry average of 23.

INVA passed 14 out of 33 due diligence checks and has strong fundamentals. Innoviva has seen its stock return 11.21% over the past year, overperforming other biotech stocks by 56 percentage points.

Innoviva has an average 1 year price target of $32.00, an upside of 55.11% from Innoviva's current stock price of $20.63.

Innoviva stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Innoviva, 25% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 25% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 12.13%, which is 9 percentage points higher than the biotech industry average of 2.94%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.29%, which is -1 percentage points lower than the biotech industry average of 2.94%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 49.4% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)

Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.55%, which is -2 percentage points lower than the biotech industry average of 2.94%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has not shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 64% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.42% in the last day, and up 0.28% over the last week. Sonnet Biotherapeutics Holdings was the among the top losers in the biotechnology industry, dropping -59.35% yesterday.

Sonnet BioTherapeutics Holdings shares are trading lower after the company announced its stockholders approved a business combination with Hyperliquid Strategies and Rorschach I.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 42 points higher than the biotech industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 27.15% in the past year. It has overperformed other stocks in the biotech industry by 72 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 100.68% in the past year. It has overperformed other stocks in the biotech industry by 146 percentage points.

3. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Innoviva's stock has gained 11.21% in the past year. It has overperformed other stocks in the biotech industry by 56 percentage points.

Are biotech stocks a good buy now?

59.96% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 47.94% over the next year.

3.31% of biotech stocks have a Zen Rating of A (Strong Buy), 6.42% of biotech stocks are rated B (Buy), 44.93% are rated C (Hold), 32.3% are rated D (Sell), and 13.04% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 155.66x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Beone Medicines (NASDAQ:ONC)

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

3. Innoviva (NASDAQ:INVA)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Innoviva (NASDAQ:INVA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Beone Medicines (NASDAQ:ONC)

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

3. Innoviva (NASDAQ:INVA)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Innoviva (NASDAQ:INVA)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.